- Home
- LTH vs PCVX Comparison
LTH vs PCVX Comparison
Compare LTH & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LTH | PCVX |
|---|---|---|
| Founded | 1992 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 6.1B |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LTH | PCVX |
|---|---|---|
| Price | $25.91 | $54.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $40.57 | ★ $98.33 |
| AVG Volume (30 Days) | ★ 2.7M | 1.1M |
| Earning Date | 05-19-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 124.32 | N/A |
| EPS | ★ 1.66 | N/A |
| Revenue | ★ $2,995,255,000.00 | N/A |
| Revenue This Year | $11.88 | N/A |
| Revenue Next Year | $11.55 | N/A |
| P/E Ratio | $15.62 | ★ N/A |
| Revenue Growth | ★ 14.28 | N/A |
| 52 Week Low | $24.14 | $28.09 |
| 52 Week High | $34.99 | $76.61 |
Technical Indicators
Market Signals| Indicator | LTH | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 40.54 | 43.37 |
| Support Level | $24.92 | $42.30 |
| Resistance Level | $26.75 | $56.04 |
| Average True Range (ATR) | 0.86 | 2.56 |
| MACD | -0.05 | -0.86 |
| Stochastic Oscillator | 26.19 | 16.00 |
Price Performance
Historical ComparisonAbout LTH Life Time Group Holdings Inc.
Life Time Group Holdings Inc is a lifestyle and leisure brand offering health, fitness, and wellness experiences to a community. It is engaged in designing, building, and operating distinctive and large, multi-use sports and athletic, professional fitness, family recreation, and spa centers in a resort-like environment, principally in residential locations of metropolitan areas in the United States and Canada.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.